2023 Q2 Form 10-Q Financial Statement

#000165495423006246 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $7.032M $7.526M $9.288M
YoY Change -46.65% -39.35% -38.37%
Cost Of Revenue $7.373M $7.394M $12.30M
YoY Change -36.91% -31.76% -27.34%
Gross Profit -$341.0K $132.0K -$3.013M
YoY Change -122.82% -91.61% 62.08%
Gross Profit Margin -4.85% 1.75% -32.44%
Selling, General & Admin $2.199M $2.359M $3.554M
YoY Change -49.98% -39.9% -34.22%
% of Gross Profit 1787.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.346M $1.196M $2.215M
YoY Change -26.89% -20.85% 65.05%
% of Gross Profit 906.06%
Operating Expenses $2.307M $2.465M $3.582M
YoY Change -47.52% -37.2% -39.95%
Operating Profit -$2.648M -$2.333M -$6.595M
YoY Change -12.46% -5.12% -15.71%
Interest Expense $1.151M $1.659M -$1.485M
YoY Change -13.91% 26.64% -5.29%
% of Operating Profit
Other Income/Expense, Net $2.625M -$1.658M $172.0K
YoY Change -271.68% 8.86% -170.78%
Pretax Income -$23.00K -$3.991M -$11.15M
YoY Change -99.49% 0.23% 11.57%
Income Tax $50.00K $49.00K -$34.00K
% Of Pretax Income
Net Earnings -$73.00K -$4.040M -$11.11M
YoY Change -98.42% -0.42% 11.23%
Net Earnings / Revenue -1.04% -53.68% -119.66%
Basic Earnings Per Share -$0.01 -$0.03
Diluted Earnings Per Share -$0.01 -$0.03 -$0.10
COMMON SHARES
Basic Shares Outstanding 112.8M shares 112.8M shares 100.6M shares
Diluted Shares Outstanding 121.8K shares 121.8K shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.422M $1.294M $1.098M
YoY Change 281.95% -78.02% -86.08%
Cash & Equivalents $8.422M $1.294M $1.098M
Short-Term Investments
Other Short-Term Assets $736.0K $1.207M $1.522M
YoY Change -74.44% -55.33% -22.98%
Inventory $9.509M $10.08M $10.78M
Prepaid Expenses
Receivables $2.683M $2.838M $4.163M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.35M $15.42M $17.56M
YoY Change -18.06% -48.66% -44.12%
LONG-TERM ASSETS
Property, Plant & Equipment $14.77M $30.79M $31.28M
YoY Change -76.37% -51.76% -51.71%
Goodwill
YoY Change
Intangibles $42.00M $42.20M $42.20K
YoY Change 103363.65% 3.76% 3.55%
Long-Term Investments
YoY Change
Other Assets $672.0K $412.0K $413.0K
YoY Change 117.48% 19.08% -0.72%
Total Long-Term Assets $111.6M $98.67M $101.3M
YoY Change 7.89% -5.89% -4.43%
TOTAL ASSETS
Total Short-Term Assets $21.35M $15.42M $17.56M
Total Long-Term Assets $111.6M $98.67M $101.3M
Total Assets $132.9M $114.1M $118.8M
YoY Change 2.67% -15.42% -13.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.074M $3.442M $2.307M
YoY Change -7.66% 48.55% -25.63%
Accrued Expenses $298.0K $432.0K $350.0K
YoY Change -64.14% -41.94% -46.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $23.45M $24.36M $24.34M
YoY Change 718.92% 9442923.26% 11013022.17%
Total Short-Term Liabilities $30.60M $31.79M $30.65M
YoY Change 163.78% 163.88% 202.78%
LONG-TERM LIABILITIES
Long-Term Debt $58.23M $38.17M $40.06M
YoY Change 4.12% 165659.08% 174839.95%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $58.23M $38.17M $40.06M
YoY Change 4.12% 165659.08% 174839.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.60M $31.79M $30.65M
Total Long-Term Liabilities $58.23M $38.17M $40.06M
Total Liabilities $88.83M $69.96M $70.71M
YoY Change 31.54% 2.16% 5.42%
SHAREHOLDERS EQUITY
Retained Earnings -$147.7M -$147.7M -$143.6M
YoY Change 15.66% 20.63%
Common Stock $191.8M $191.8M $191.7M
YoY Change 1.14% 1.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.11M $44.14M $48.12M
YoY Change
Total Liabilities & Shareholders Equity $132.9M $114.1M $118.8M
YoY Change 2.67% -15.42% -13.51%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$73.00K -$4.040M -$11.11M
YoY Change -98.42% -0.42% 11.23%
Depreciation, Depletion And Amortization $1.346M $1.196M $2.215M
YoY Change -26.89% -20.85% 65.05%
Cash From Operating Activities -$1.335M $912.0K -$130.0K
YoY Change -46.86% -204.35% -98.29%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $29.00K $1.330M
YoY Change -98.17% -94.0% -186.59%
Acquisitions
YoY Change
Other Investing Activities $41.00K
YoY Change -91.56%
Cash From Investing Activities $10.00K -$29.00K -$1.289M
YoY Change -101.85% -94.0% 22.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.453M -$687.0K -775.0K
YoY Change -1448.17% 6.68% 63.85%
NET CHANGE
Cash From Operating Activities -1.335M $912.0K -130.0K
Cash From Investing Activities 10.00K -$29.00K -1.289M
Cash From Financing Activities 8.453M -$687.0K -775.0K
Net Change In Cash 7.128M $196.0K -2.194M
YoY Change -293.64% -109.8% -75.91%
FREE CASH FLOW
Cash From Operating Activities -$1.335M $912.0K -$130.0K
Capital Expenditures -$10.00K $29.00K $1.330M
Free Cash Flow -$1.325M $883.0K -$1.460M
YoY Change -32.57% -165.07% -75.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 lowlf Convertible Debentures Current
ConvertibleDebenturesCurrent
21626000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001838128
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
608000 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 lowlf Convertible Debentures Current
ConvertibleDebenturesCurrent
21398000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3550000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3654000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
31787000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30650000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000 usd
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56254
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LOWELL FARMS INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3037317
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
19 Quail Run Circle - Suite B
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salinas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93907
CY2023Q1 dei City Area Code
CityAreaCode
831
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
998-8214
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
112761904 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1294000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1098000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
953000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1053000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2838000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4163000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
10779000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1207000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1522000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
15423000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
17562000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30792000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31284000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25367000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27362000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
42101000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
42202000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
412000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
413000 usd
CY2023Q1 us-gaap Assets
Assets
114095000 usd
CY2022Q4 us-gaap Assets
Assets
118823000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3442000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2307000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
432000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
350000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
273000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
282000 usd
CY2023Q1 lowlf Lease Obligation Current Portion
LeaseObligationCurrentPortion
2464000 usd
CY2022Q4 lowlf Lease Obligation Current Portion
LeaseObligationCurrentPortion
2659000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
2000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3000 usd
CY2023Q1 lowlf Lease Obligation Non Current
LeaseObligationNonCurrent
29505000 usd
CY2022Q4 lowlf Lease Obligation Non Current
LeaseObligationNonCurrent
31340000 usd
CY2023Q1 lowlf Convertible Debentures Non Current
ConvertibleDebenturesNonCurrent
0 usd
CY2022Q4 lowlf Convertible Debentures Non Current
ConvertibleDebenturesNonCurrent
0 usd
CY2023Q1 us-gaap Participating Mortgage Loans Mortgage Obligations Amount
ParticipatingMortgageLoansMortgageObligationsAmount
8664000 usd
CY2022Q4 us-gaap Participating Mortgage Loans Mortgage Obligations Amount
ParticipatingMortgageLoansMortgageObligationsAmount
8713000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
69958000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
70706000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
191802000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
191742000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147665000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-143625000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
44137000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48117000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114095000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118823000 usd
CY2023Q1 us-gaap Revenues
Revenues
7526000 usd
CY2022Q1 us-gaap Revenues
Revenues
12409000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7394000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10835000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
132000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1574000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1624000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2164000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
735000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1761000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
106000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
108000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2465000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
4033000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2333000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2459000 usd
CY2023Q1 lowlf Other Income Expense
OtherIncomeExpense
1000 usd
CY2022Q1 lowlf Other Income Expense
OtherIncomeExpense
-143000 usd
CY2023Q1 lowlf Unrealized Change In Fair Value Of Investment
UnrealizedChangeInFairValueOfInvestment
0 usd
CY2022Q1 lowlf Unrealized Change In Fair Value Of Investment
UnrealizedChangeInFairValueOfInvestment
-70000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1659000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1310000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1658000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1523000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3991000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3982000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4040000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4057000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121770 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100118 shares
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
348000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121770 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100118 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
48117000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4040000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
60000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
44137000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70307000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4057000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
161000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
66411000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4040000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4057000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1196000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1511000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
249000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
226000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
60000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
161000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
88000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
243000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-70000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1237000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2335000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-695000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2464000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-315000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
726000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1111000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1827000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
912000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-874000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
483000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-483000 usd
CY2023Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
608000 usd
CY2022Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
586000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
79000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
58000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-687000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-644000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
196000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2001000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1098000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7887000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1294000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5886000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
821000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1018000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
268000 usd
CY2023Q1 lowlf Purchase Of Property And Equipment Not Yet Paid
PurchaseOfPropertyAndEquipmentNotYetPaid
8000 usd
CY2022Q1 lowlf Purchase Of Property And Equipment Not Yet Paid
PurchaseOfPropertyAndEquipmentNotYetPaid
79000 usd
CY2022Q4 lowlf Licenses And Payments
LicensesAndPayments
146000 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
40000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
102000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1207000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1522000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
158000 usd
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
46000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
17000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
411000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The global COVID-19 pandemic impacted the operations and purchasing decisions of companies worldwide. It also created significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If the COVID-19 pandemic were to have an increased forward-looking impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.</p>
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
612000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
595000 usd
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
163000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
235000 usd
CY2023Q1 us-gaap Supplies
Supplies
155000 usd
CY2022Q4 us-gaap Supplies
Supplies
375000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
34000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
69000 usd
CY2023Q1 lowlf Licenses And Payments
LicensesAndPayments
203000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
7430000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7431000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
654000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
940000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2000000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2408000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
10084000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
10779000 usd
CY2023Q1 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
1448000 usd
CY2022Q4 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
921000 usd
CY2023Q1 lowlf Equipment Purchase Accrual
EquipmentPurchaseAccrual
724000 usd
CY2022Q4 lowlf Equipment Purchase Accrual
EquipmentPurchaseAccrual
724000 usd
CY2023Q1 lowlf Erc Commission Accrual
ErcCommissionAccrual
441000 usd
CY2022Q4 lowlf Erc Commission Accrual
ErcCommissionAccrual
441000 usd
CY2023Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
278000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
948000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
125000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
97000 usd
CY2023Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
77000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
72651000 usd
CY2023Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
29000 usd
CY2023Q1 lowlf Propertyplantandequipmentlease Remeasurement
PropertyplantandequipmentleaseRemeasurement
-1422000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71258000 usd
CY2023Q1 lowlf Accumulated Depreciation Beginning
AccumulatedDepreciationBeginning
14004000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1095000 usd
CY2023Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 usd
CY2023Q1 lowlf Accumulated Depreciation Ending
AccumulatedDepreciationEnding
15099000 usd
CY2023Q1 lowlf Property Plant And Equipment Net Book Value
PropertyPlantAndEquipmentNetBookValue
56159000 usd
CY2022Q4 lowlf Property Plant And Equipment Net Book Value
PropertyPlantAndEquipmentNetBookValue
58646000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1095000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
1429000 usd
CY2023Q1 lowlf Description Of Remeasurement Of Right Of Use Assetlease Liability
DescriptionOfRemeasurementOfRightOfUseAssetleaseLiability
These revised leases resulted in a remeasurement of both the right of use asset and lease liability of $1,422
CY2022Q4 lowlf Definite Lived Intangible Assets
DefiniteLivedIntangibleAssets
42765000 usd
CY2023Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
CY2023Q1 lowlf Finite Lived Intangible Assets Agreement Termination
FiniteLivedIntangibleAssetsAgreementTermination
0 usd
CY2023Q1 lowlf Definite Life Intangibles Cost Ending Balance
DefiniteLifeIntangiblesCostEndingBalance
42765000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
563000 usd
CY2023Q1 lowlf Adjustment For Amortizations
AdjustmentForAmortizations
101000 usd
CY2022Q4 lowlf Accumulated Amortization Ending
AccumulatedAmortizationEnding
664000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42202000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42101000 usd
CY2023Q1 lowlf Adjustment For Amortizations
AdjustmentForAmortizations
101000 usd
CY2022Q1 lowlf Adjustment For Amortizations
AdjustmentForAmortizations
82000 usd
CY2023Q1 lowlf Future Amortization Expense
FutureAmortizationExpense
399000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
173435000 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
173435000 shares
CY2023Q1 lowlf Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P14Y10M24D
CY2023Q1 lowlf Total Short Term Debt
TotalShortTermDebt
21899000 usd
CY2022Q4 lowlf Total Short Term Debt
TotalShortTermDebt
21680000 usd
CY2023Q1 lowlf Total Long Term Debt
TotalLongTermDebt
8666000 usd
CY2022Q4 lowlf Total Long Term Debt
TotalLongTermDebt
8716000 usd
CY2023Q1 lowlf Total Indebtness
TotalIndebtness
30565000 usd
CY2022Q4 lowlf Total Indebtness
TotalIndebtness
30396000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
532000 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
759000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
22361000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
290000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
33000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
8390000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
31371000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33999000 usd
CY2023Q1 lowlf Lease Remeasurement
LeaseRemeasurement
-1422000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
31969000 usd
CY2023Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2464000 usd
CY2022Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2659000 usd
CY2023Q1 lowlf Lease Obligation Long Term Portion
LeaseObligationLongTermPortion
29505000 usd
CY2022Q4 lowlf Lease Obligation Long Term Portion
LeaseObligationLongTermPortion
31340000 usd
CY2023Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
31969000 usd
CY2022Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
33999000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060 pure
CY2022 lowlf Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P14Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060 pure
CY2023Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
573000 usd
CY2022Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
817000 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
500000 usd
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
573000 usd
CY2023Q1 lowlf Total Components Of Lease Expense
TotalComponentsOfLeaseExpense
1073000 usd
CY2022Q1 lowlf Total Components Of Lease Expense
TotalComponentsOfLeaseExpense
1390000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3298000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3800000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2993000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2938000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
36621000 usd
CY2023Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
17680000 usd
CY2023Q1 lowlf Total Future Lease Payments
TotalFutureLeasePayments
31970000 usd
CY2023Q1 lowlf Proceeds From Issuance Of Stock Options
ProceedsFromIssuanceOfStockOptions
13200000 shares
CY2023Q1 lowlf Stock Option For Future Grant
StockOptionForFutureGrant
5000000 shares
CY2023Q1 lowlf Vesting Period Descriptions
VestingPeriodDescriptions
The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
60000 usd
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
161000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10069000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.47
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 lowlf Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 lowlf Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodIntrinsicValue
0 usd
CY2023Q1 lowlf Stock Options Cancelled
StockOptionsCancelled
-1462000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.37
CY2023Q1 lowlf Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8607000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.49
CY2023Q1 lowlf Weighted Average Remaining Contactual Life Outstanding Beginning Balance
WeightedAverageRemainingContactualLifeOutstandingBeginningBalance
P4Y7M6D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4164000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.68
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8607000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.49
CY2023Q1 lowlf Weighted Average Remaining Contactual Life Outstanding Ending Balance
WeightedAverageRemainingContactualLifeOutstandingEndingBalance
P4Y7M6D
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.31
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
437000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y3M18D
CY2023Q1 lowlf Rsus Outstanding Beginning Balance
RsusOutstandingBeginningBalance
208 shares
CY2023Q1 lowlf Weighted Average Fair Value Outstanding Ending Balance
WeightedAverageFairValueOutstandingEndingBalance
1.1
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
80 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.1
CY2023Q1 lowlf Rsus Outstanding Ending Balance
RsusOutstandingEndingBalance
128000 usd
CY2023Q1 lowlf Weighted Average Fair Value Outstanding Beginning Balance
WeightedAverageFairValueOutstandingBeginningBalance
1.1
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0124 pure
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0188 pure
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4040000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4057000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121770 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100118 shares
CY2023Q1 lowlf Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
121770 shares
CY2022Q1 lowlf Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
100118 shares
CY2023Q1 lowlf Basic Shares
BasicShares
121770 shares
CY2022Q1 lowlf Basic Shares
BasicShares
100118 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
121770 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
100118 shares
CY2023Q1 lowlf Total Remaining Purchase Commitment
TotalRemainingPurchaseCommitment
290000 usd
CY2023Q1 lowlf Remaining Purchase Commitment
RemainingPurchaseCommitment
220000 usd
CY2023Q1 lowlf Due Date Of Commitment
DueDateOfCommitment
2023
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1624000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2164000 usd
CY2023Q1 lowlf Related Party Transaction Sales To Related Party
RelatedPartyTransactionSalesToRelatedParty
93000 usd
CY2022Q1 lowlf Related Party Transaction Sales To Related Party
RelatedPartyTransactionSalesToRelatedParty
36000 usd
CY2023Q1 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
139000 usd
CY2022Q1 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
26000 usd
CY2023Q1 lowlf Lease Term
LeaseTerm
P12M

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
lowlf-20230331_cal.xml Edgar Link unprocessable
0001654954-23-006246-index-headers.html Edgar Link pending
0001654954-23-006246-index.html Edgar Link pending
0001654954-23-006246.txt Edgar Link pending
0001654954-23-006246-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lowlf-20230331.xsd Edgar Link pending
lowlf_10q.htm Edgar Link pending
lowlf_ex311.htm Edgar Link pending
lowlf_ex312.htm Edgar Link pending
lowlf_ex321.htm Edgar Link pending
lowlf_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
lowlf-20230331_def.xml Edgar Link unprocessable
lowlf-20230331_lab.xml Edgar Link unprocessable
lowlf-20230331_pre.xml Edgar Link unprocessable
lowlf_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending